| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.87e-05 | 118 | 110 | 6 | GO:0003774 | |
| GeneOntologyCellularComponent | myosin complex | 2.38e-04 | 59 | 107 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYL1 MYOM1 CENPE MYO9A HAUS3 POLR2M NEB RYR3 DNAI1 HOOK3 LMNB1 DNAH17 KRT20 MYH15 SPAG17 MX2 | 3.21e-04 | 1179 | 107 | 16 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYL1 MYOM1 CENPE MYO9A HAUS3 POLR2M NEB RYR3 DNAI1 HOOK3 LMNB1 DNAH17 KRT20 MYH15 SPAG17 MX2 | 3.46e-04 | 1187 | 107 | 16 | GO:0099081 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | GAPVD1 CENPE RBM33 TOPAZ1 KTN1 BEND4 NEB RYR3 DNAI1 SNX14 VPS13D CCAR1 PLCB4 ASCC3 GOLGA1 | 7.58e-11 | 497 | 112 | 15 | 36774506 |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 7.06e-09 | 8 | 112 | 4 | 12634303 | |
| Pubmed | ROCK2 PDE2A CENPE KTN1 GRIN2A PTK2 HOOK3 AKAP9 LMNB1 KCNB1 MAD1L1 CCAR1 SMARCC1 GOLGA1 | 2.75e-06 | 963 | 112 | 14 | 28671696 | |
| Pubmed | 8.06e-06 | 222 | 112 | 7 | 35941108 | ||
| Pubmed | PMS1 SEMA3C TTC28 ANGEL1 LAMC2 CWC22 ANKRD27 PTK2 ZNHIT6 CCAR1 SMARCC1 | 8.51e-06 | 650 | 112 | 11 | 38777146 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 21562308 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 18615577 | ||
| Pubmed | Microtubule-dependent association of AKAP350A and CCAR1 with RNA stress granules. | 1.03e-05 | 2 | 112 | 2 | 19073175 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.32e-05 | 361 | 112 | 8 | 26167880 | |
| Pubmed | Caffeine inhibits migration in glioma cells through the ROCK-FAK pathway. | 3.08e-05 | 3 | 112 | 2 | 25011614 | |
| Pubmed | Pluripotency transcription factors and Tet1/2 maintain Brd4-independent stem cell identity. | 3.08e-05 | 3 | 112 | 2 | 29662175 | |
| Pubmed | Mad1 promotes chromosome congression by anchoring a kinesin motor to the kinetochore. | 3.08e-05 | 3 | 112 | 2 | 26258632 | |
| Pubmed | FXR promotes endothelial cell motility through coordinated regulation of FAK and MMP-9. | 3.08e-05 | 3 | 112 | 2 | 19150878 | |
| Pubmed | CDH17 Is a More Sensitive Marker for Gastric Adenocarcinoma Than CK20 and CDX2. | 3.08e-05 | 3 | 112 | 2 | 28029907 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CUL4B PMS1 CHERP RBM33 KTN1 CWC22 BPTF LMNB1 BRD4 SUGP1 CCAR1 SMARCC1 | 6.06e-05 | 954 | 112 | 12 | 36373674 |
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 30154425 | ||
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 17938250 | ||
| Pubmed | ROCK2 KTN1 SANBR ANKRD26 CCDC150 CAGE1 NEB STK31 BPTF LMNB1 CCAR1 SMARCC1 KRT20 MYH15 SPAG17 | 6.16e-05 | 1442 | 112 | 15 | 35575683 | |
| Pubmed | 7.42e-05 | 549 | 112 | 9 | 38280479 | ||
| Pubmed | Histone H3 lysine 9 methyltransferases, G9a and GLP are essential for cardiac morphogenesis. | 8.01e-05 | 26 | 112 | 3 | 23892084 | |
| Pubmed | NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. | 8.99e-05 | 27 | 112 | 3 | 23395962 | |
| Pubmed | CUL4B ROCK2 GAPVD1 TBC1D15 NBEAL1 KTN1 VPS13D LMNB1 TMEM131L | 9.61e-05 | 568 | 112 | 9 | 37774976 | |
| Pubmed | NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler. | 1.02e-04 | 5 | 112 | 2 | 26626481 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 GAPVD1 TTC28 MYO9A ANKRD26 ANKRD27 VPS13D AKAP9 BRD4 MAD1L1 NADK | 1.09e-04 | 861 | 112 | 11 | 36931259 |
| Pubmed | A Y2H-seq approach defines the human protein methyltransferase interactome. | 1.25e-04 | 342 | 112 | 7 | 23455924 | |
| Pubmed | CUL4B GAPVD1 CHERP TTC28 CENPE RBM33 KTN1 PAPOLG SUGP1 TMEM131L | 1.34e-04 | 733 | 112 | 10 | 34672954 | |
| Pubmed | 1.53e-04 | 6 | 112 | 2 | 23588386 | ||
| Pubmed | 1.83e-04 | 486 | 112 | 8 | 20936779 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CUL4B ROCK2 GAPVD1 PAPOLG BPTF BRD4 MAD1L1 CCAR1 SMARCC1 CDH17 | 2.07e-04 | 774 | 112 | 10 | 15302935 |
| Pubmed | 2.13e-04 | 497 | 112 | 8 | 23414517 | ||
| Pubmed | 2.14e-04 | 7 | 112 | 2 | 11212352 | ||
| Pubmed | 2.14e-04 | 7 | 112 | 2 | 38109525 | ||
| Pubmed | 2.14e-04 | 7 | 112 | 2 | 33139725 | ||
| Pubmed | 2.25e-04 | 169 | 112 | 5 | 31462741 | ||
| Pubmed | 2.29e-04 | 638 | 112 | 9 | 33239621 | ||
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 2.31e-04 | 170 | 112 | 5 | 23314748 | |
| Pubmed | 2.35e-04 | 504 | 112 | 8 | 34432599 | ||
| Pubmed | 2.39e-04 | 268 | 112 | 6 | 33640491 | ||
| Pubmed | CUL4B TTC28 ABCA12 GPT ANGEL1 ZNF829 ZNF518A BPTF ZNHIT6 BRD4 SMARCC1 ASCC3 | 2.61e-04 | 1116 | 112 | 12 | 31753913 | |
| Pubmed | 2.84e-04 | 8 | 112 | 2 | 24659802 | ||
| Pubmed | 2.84e-04 | 8 | 112 | 2 | 14602821 | ||
| Pubmed | A genetic map of mouse chromosome 1 near the Lsh-Ity-Bcg disease resistance locus. | 2.84e-04 | 8 | 112 | 2 | 1970800 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CUL4B GAPVD1 TTC28 CENPE ANKRD26 HAUS3 HOOK3 LMNB1 NADK CPLANE1 | 4.45e-04 | 853 | 112 | 10 | 28718761 |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 4.53e-04 | 701 | 112 | 9 | 30196744 | |
| Pubmed | ZMYND10 functions in a chaperone relay during axonemal dynein assembly. | 4.55e-04 | 10 | 112 | 2 | 29916806 | |
| Pubmed | Tropomodulin isoforms regulate thin filament pointed-end capping and skeletal muscle physiology. | 4.55e-04 | 10 | 112 | 2 | 20368620 | |
| Pubmed | 4.55e-04 | 10 | 112 | 2 | 19506036 | ||
| Pubmed | 4.87e-04 | 708 | 112 | 9 | 39231216 | ||
| Pubmed | 5.53e-04 | 116 | 112 | 4 | 21282530 | ||
| Pubmed | 5.55e-04 | 11 | 112 | 2 | 30718399 | ||
| Pubmed | Inactivation of Myf-6 and Myf-5 genes in mice leads to alterations in skeletal muscle development. | 5.55e-04 | 11 | 112 | 2 | 7720708 | |
| Pubmed | 5.55e-04 | 11 | 112 | 2 | 12917342 | ||
| Pubmed | Thbs1 regulates skeletal muscle mass in a TGFβ-Smad2/3-ATF4-dependent manner. | 5.55e-04 | 11 | 112 | 2 | 38678560 | |
| Pubmed | 5.55e-04 | 11 | 112 | 2 | 22242143 | ||
| Pubmed | Regulation of the CUL3 Ubiquitin Ligase by a Calcium-Dependent Co-adaptor. | 5.71e-04 | 50 | 112 | 3 | 27716508 | |
| Pubmed | 5.90e-04 | 118 | 112 | 4 | 26264872 | ||
| Pubmed | 5.95e-04 | 209 | 112 | 5 | 36779422 | ||
| Pubmed | WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation. | 6.40e-04 | 52 | 112 | 3 | 30655611 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 6.42e-04 | 736 | 112 | 9 | 29676528 | |
| Pubmed | Molecular diversity of myofibrillar proteins: gene regulation and functional significance. | 6.64e-04 | 12 | 112 | 2 | 8618961 | |
| Pubmed | 7.20e-04 | 218 | 112 | 5 | 19460752 | ||
| Pubmed | Global discovery of erythroid long noncoding RNAs reveals novel regulators of red cell maturation. | 7.55e-04 | 55 | 112 | 3 | 24200680 | |
| Pubmed | 7.83e-04 | 13 | 112 | 2 | 22051675 | ||
| Pubmed | 8.33e-04 | 469 | 112 | 7 | 27634302 | ||
| Pubmed | 9.12e-04 | 14 | 112 | 2 | 19874786 | ||
| Pubmed | Global phosphoproteome of HT-29 human colon adenocarcinoma cells. | 9.27e-04 | 59 | 112 | 3 | 16083285 | |
| Pubmed | An inter-species protein-protein interaction network across vast evolutionary distance. | 9.87e-04 | 483 | 112 | 7 | 27107014 | |
| Pubmed | Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport. | 1.05e-03 | 15 | 112 | 2 | 21948112 | |
| Pubmed | 1.17e-03 | 64 | 112 | 3 | 20332099 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CUL4B GAPVD1 CHERP CENPE HAUS3 CWC22 ZNHIT6 LMNB1 MAD1L1 CCAR1 SMARCC1 | 1.28e-03 | 1155 | 112 | 11 | 20360068 |
| Pubmed | 1.29e-03 | 506 | 112 | 7 | 30890647 | ||
| Pubmed | 1.35e-03 | 251 | 112 | 5 | 31076518 | ||
| Pubmed | 1.35e-03 | 17 | 112 | 2 | 26102480 | ||
| Pubmed | 1.35e-03 | 17 | 112 | 2 | 24086760 | ||
| Pubmed | 1.35e-03 | 17 | 112 | 2 | 34622152 | ||
| Pubmed | 1.52e-03 | 18 | 112 | 2 | 23087374 | ||
| Pubmed | 1.52e-03 | 18 | 112 | 2 | 19587446 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 1.58e-03 | 154 | 112 | 4 | 16055720 | |
| Pubmed | 1.65e-03 | 263 | 112 | 5 | 34702444 | ||
| Pubmed | 1.70e-03 | 19 | 112 | 2 | 31345929 | ||
| Pubmed | A high-resolution molecular atlas of the fetal mouse lower urogenital tract. | 1.85e-03 | 75 | 112 | 3 | 21905163 | |
| Pubmed | 1.88e-03 | 20 | 112 | 2 | 9128241 | ||
| Pubmed | 1.88e-03 | 20 | 112 | 2 | 21689717 | ||
| Pubmed | 1.89e-03 | 399 | 112 | 6 | 35987950 | ||
| Pubmed | 2.07e-03 | 21 | 112 | 2 | 30270038 | ||
| Pubmed | 2.07e-03 | 21 | 112 | 2 | 24407287 | ||
| Pubmed | 2.13e-03 | 167 | 112 | 4 | 25659891 | ||
| Pubmed | 2.15e-03 | 79 | 112 | 3 | 25921334 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.27e-03 | 283 | 112 | 5 | 30585729 | |
| Pubmed | Epithelial Wnt/βcatenin signalling is essential for epididymal coiling. | 2.28e-03 | 22 | 112 | 2 | 26934381 | |
| Pubmed | 2.39e-03 | 418 | 112 | 6 | 34709266 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 2.42e-03 | 724 | 112 | 8 | 36232890 | |
| Pubmed | 2.49e-03 | 23 | 112 | 2 | 19240791 | ||
| Pubmed | A general approach for investigating enzymatic pathways and substrates for ubiquitin-like modifiers. | 2.71e-03 | 24 | 112 | 2 | 16620772 | |
| Pubmed | 2.71e-03 | 24 | 112 | 2 | 17182866 | ||
| Pubmed | 3.08e-03 | 591 | 112 | 7 | 15231748 | ||
| Pubmed | TFAM is required for maturation of the fetal and adult intestinal epithelium. | 3.18e-03 | 26 | 112 | 2 | 29684311 | |
| Pubmed | An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. | 3.21e-03 | 91 | 112 | 3 | 20362542 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TBC1D15 TTC28 CENPE RBM33 KTN1 ANGEL1 ATF6 VPS13D AKAP9 LMNB1 TRMT5 PGBD5 | 3.22e-03 | 1496 | 112 | 12 | 32877691 |
| Interaction | FBXO22 interactions | GAPVD1 CENPE RBM33 TOPAZ1 KTN1 BEND4 NEB RYR3 DNAI1 SNX14 VPS13D CCAR1 PLCB4 ASCC3 GOLGA1 | 3.12e-07 | 540 | 112 | 15 | int:FBXO22 |
| Interaction | ANKRD20A4P interactions | 3.30e-06 | 6 | 112 | 3 | int:ANKRD20A4P | |
| Interaction | ANKRD20A2P interactions | 5.75e-06 | 7 | 112 | 3 | int:ANKRD20A2P | |
| Interaction | ANKRD20A1 interactions | 2.67e-05 | 11 | 112 | 3 | int:ANKRD20A1 | |
| GeneFamily | Ankyrin repeat domain containing | 2.73e-04 | 242 | 67 | 6 | 403 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.56e-04 | 181 | 67 | 5 | 694 | |
| GeneFamily | VPS9 domain containing | 5.97e-04 | 10 | 67 | 2 | 928 | |
| GeneFamily | Dyneins, axonemal | 1.77e-03 | 17 | 67 | 2 | 536 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 2.98e-03 | 22 | 67 | 2 | 579 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.00e-03 | 161 | 67 | 4 | 593 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_POSITIVE | 1.65e-06 | 84 | 112 | 6 | M40895 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PMS1 ROCK2 SEMA3C GAPVD1 TTC28 CENPE PTK2 BPTF SEC24D AKAP9 LMNB1 MAD1L1 TMEM131L PLCB4 ASCC3 | 3.74e-06 | 856 | 112 | 15 | M4500 |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP | 2.05e-05 | 194 | 112 | 7 | M7467 | |
| Coexpression | GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_UP | 2.27e-05 | 197 | 112 | 7 | M5964 | |
| Coexpression | GSE3039_B2_VS_B1_BCELL_UP | 2.42e-05 | 199 | 112 | 7 | M6450 | |
| Coexpression | GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_DN | 2.42e-05 | 199 | 112 | 7 | M4328 | |
| Coexpression | GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN | 5.34e-05 | 154 | 112 | 6 | M6824 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CUL4B PMS1 ROCK2 CENPE KTN1 SANBR ANKRD26 HAUS3 CWC22 SLC25A37 PREX2 PAPOLG BPTF HOOK3 AKAP9 BRD4 MAD1L1 CCAR1 SMARCC1 TMEM131L KRT20 CPLANE1 DEUP1 | 9.44e-07 | 1459 | 108 | 23 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CUL4B PMS1 ROCK2 CENPE KTN1 SANBR ANKRD26 HAUS3 SLC25A37 PAPOLG BPTF HOOK3 AKAP9 BRD4 MAD1L1 CCAR1 SMARCC1 TMEM131L CPLANE1 | 1.76e-05 | 1257 | 108 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_500 | 4.09e-05 | 38 | 108 | 4 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 5.72e-05 | 192 | 108 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ROCK2 CENPE MYO9A RBM33 KTN1 SANBR ANKRD26 ZNF518A PAPOLG AKAP9 BTD CCAR1 TMEM131L GOLGA1 | 8.16e-05 | 831 | 108 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.07e-04 | 92 | 108 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | CUL4B ROCK2 CENPE SPATA24 ANKRD26 HAUS3 CWC22 SLC25A37 PREX2 ZNF518A MMRN1 HOOK3 AKAP9 BRD4 RASGEF1B CCAR1 SMARCC1 TMEM131L FGF7 | 1.42e-04 | 1468 | 108 | 19 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | CUL4B ROCK2 CENPE SPATA24 ANKRD26 HAUS3 SLC25A37 ZNF518A MMRN1 HOOK3 AKAP9 BRD4 RASGEF1B CCAR1 SMARCC1 TMEM131L FGF7 | 1.71e-04 | 1241 | 108 | 17 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KIAA0408 TMPRSS15 ABCA12 TEX11 NEB RYR3 GUCY2F MYH15 MYO15A SPAG17 | 4.04e-11 | 184 | 112 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KIAA0408 TMPRSS15 ABCA12 TEX11 NEB RYR3 GUCY2F MYH15 MYO15A SPAG17 | 4.04e-11 | 184 | 112 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KIAA0408 TMPRSS15 ABCA12 TEX11 NEB RYR3 GUCY2F MYH15 MYO15A SPAG17 | 4.04e-11 | 184 | 112 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | TTC21A SANBR ANKRD26 CFAP43 LRRC4 ZBBX AKAP9 KCNB1 SPAG17 CPLANE1 | 7.91e-11 | 197 | 112 | 10 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-07 | 178 | 112 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Control-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | RAD21L1 ANKRD20A2P ANKRD20A3P ANKRD20A8P SERPINB9 ANKRD20A4P ANKRD20A1 | 4.30e-07 | 184 | 112 | 7 | c6affa0b12510363258f65e46bf2d47bf4a8e75f |
| ToppCell | Control-Myeloid-cDC1|Control / Disease state, Lineage and Cell class | RAD21L1 ANKRD20A2P ANKRD20A3P ANKRD20A8P SERPINB9 ANKRD20A4P ANKRD20A1 | 4.63e-07 | 186 | 112 | 7 | b05c394aa3573ba855abc3066739ca193883b0c3 |
| ToppCell | E18.5-Epithelial-Epithelial_Airway|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.34e-07 | 190 | 112 | 7 | 5c012935ea5e35a2d0d08ea7dc04ffbe3c2a10ac | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.54e-07 | 191 | 112 | 7 | acd844b477a069b2dcf07b2998e1b5c87dc0eb94 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 5.54e-07 | 191 | 112 | 7 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P PTK2 SERPINB9 ANKRD20A4P ANKRD20A1 | 5.54e-07 | 191 | 112 | 7 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 5.54e-07 | 191 | 112 | 7 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 6.58e-07 | 196 | 112 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 6.58e-07 | 196 | 112 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 7.29e-07 | 199 | 112 | 7 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.54e-07 | 200 | 112 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | AT2_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.01e-06 | 131 | 112 | 6 | ff4e618bd944f852bbd34438f740187aca82460f | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.89e-06 | 157 | 112 | 6 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.72e-06 | 164 | 112 | 6 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | Ciliated_cells-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 3.99e-06 | 166 | 112 | 6 | 4b1056aad8a99827835242b8ab0c7f2bb84471f1 | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_precursor|Distal / Age, Tissue, Lineage and Cell class | 4.13e-06 | 167 | 112 | 6 | 442ea71a581ed5a547a214132b9f1b0243fd0895 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.42e-06 | 169 | 112 | 6 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Deuterosomal|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.89e-06 | 172 | 112 | 6 | 08ad76412c9cc3504141797b44b88478ced87476 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.23e-06 | 174 | 112 | 6 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | 18-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class | 6.98e-06 | 183 | 112 | 6 | a75cda2131755931117c387f2e0ae3394efa8e80 | |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P SERPINB9 ANKRD20A4P ANKRD20A1 | 7.20e-06 | 184 | 112 | 6 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 |
| ToppCell | IPF-Myeloid-cDC1|World / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P SERPINB9 ANKRD20A4P ANKRD20A1 | 7.66e-06 | 186 | 112 | 6 | 962c2dada19185628ead77c32fcb07fa95114247 |
| ToppCell | Control-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 7.66e-06 | 186 | 112 | 6 | 3de803dee3ef10eb85a2b47d3f93385214e5b0ff | |
| ToppCell | 18-Distal-Epithelial-Multiciliated_precursor|Distal / Age, Tissue, Lineage and Cell class | 7.66e-06 | 186 | 112 | 6 | 58ab1360a1730655a5939295ba05997ac4a2d14e | |
| ToppCell | IPF-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P SERPINB9 ANKRD20A4P ANKRD20A1 | 8.14e-06 | 188 | 112 | 6 | 47bb6caf84f70a1cda7d09803afdfd5182772e66 |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 8.14e-06 | 188 | 112 | 6 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | IPF-Myeloid-cDC1|IPF / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P SERPINB9 ANKRD20A4P ANKRD20A1 | 8.14e-06 | 188 | 112 | 6 | 2331a2bae1383820d598e93aa86c75b101069bac |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.65e-06 | 190 | 112 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.91e-06 | 191 | 112 | 6 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.91e-06 | 191 | 112 | 6 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.91e-06 | 191 | 112 | 6 | e8d56e9f43943e9cc4dce83f2c234f19c2dd487d | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 8.91e-06 | 191 | 112 | 6 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.91e-06 | 191 | 112 | 6 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.91e-06 | 191 | 112 | 6 | 52e8d7dfaf1ebb6df8bf3a1f4546af59faa67657 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.91e-06 | 191 | 112 | 6 | 1e21de183a9c09cfb6aad3f9b948087fb6bad061 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.91e-06 | 191 | 112 | 6 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | COPD-Myeloid-cDC1|COPD / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P SERPINB9 ANKRD20A4P ANKRD20A1 | 9.18e-06 | 192 | 112 | 6 | bd3d00b094d92463b06023361a71240851a542b8 |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.18e-06 | 192 | 112 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 9.18e-06 | 192 | 112 | 6 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.18e-06 | 192 | 112 | 6 | bb7eb51bc079acacde42d8e55ba06d03eba2ea28 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 9.46e-06 | 193 | 112 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.46e-06 | 193 | 112 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.46e-06 | 193 | 112 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.74e-06 | 194 | 112 | 6 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.00e-05 | 195 | 112 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.00e-05 | 195 | 112 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.00e-05 | 195 | 112 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.00e-05 | 195 | 112 | 6 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.03e-05 | 196 | 112 | 6 | fe8d3f45a64323947c36b127355d5940eb56c0ca | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.03e-05 | 196 | 112 | 6 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.03e-05 | 196 | 112 | 6 | 526d037bb12d81f1c235c60ddc787fbad0bbad77 | |
| ToppCell | wk_20-22-Epithelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.06e-05 | 197 | 112 | 6 | 468071c1911cdf8e8806a78dbceb95379e28ae91 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 1.06e-05 | 197 | 112 | 6 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-05 | 197 | 112 | 6 | 3cd1c816bc7a57278b2ef615b69545356ab8f522 | |
| ToppCell | PSB|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.09e-05 | 198 | 112 | 6 | 4e6b0d1abc55d7a0d89bd7ecf0f13dc5bed66626 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.13e-05 | 199 | 112 | 6 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.13e-05 | 199 | 112 | 6 | e22767758459deabefee2ea9d2b9b279cacfd015 | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM2|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.13e-05 | 199 | 112 | 6 | 2f9f75c2c7e00a855ce11411ff7b8271c9eec45f | |
| ToppCell | ASK452-Epithelial|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.13e-05 | 199 | 112 | 6 | e8778d4d2bc7e15b4c7989a93e5808a76738df46 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.13e-05 | 199 | 112 | 6 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.13e-05 | 199 | 112 | 6 | 37e3c00b127be4985843d8758c0ae0384f3bccfe | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.13e-05 | 199 | 112 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.13e-05 | 199 | 112 | 6 | 97888e2ae11178d1d526be1d7c518c51cffe976b | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.13e-05 | 199 | 112 | 6 | 64bb1258e7ba56afd937c5ae47226fff7a1ccadb | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.13e-05 | 199 | 112 | 6 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 112 | 6 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 112 | 6 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 200 | 112 | 6 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | Severe-Myeloid-Macrophages-FCN1_high|Severe / Condition, Lineage, Cell class and cell subclass | 1.16e-05 | 200 | 112 | 6 | 449623d6786e30d493f68156b3f1ee8caf9265a6 | |
| ToppCell | distal-2-Epithelial|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.16e-05 | 200 | 112 | 6 | 2fc1e95706f212bf18ecdf6eb5b3182ac98c9b52 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-2|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.89e-05 | 141 | 112 | 5 | 1baa054c2ae3b446d1954244b7fbf8af824ef345 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.64e-05 | 148 | 112 | 5 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.64e-05 | 148 | 112 | 5 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_2|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.86e-05 | 75 | 112 | 4 | 9a82db6281326acc534b800e02b262a8617a147e | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr-Polydendrocyte.Tnr.Pdgfa_(Pdgfa)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.86e-05 | 75 | 112 | 4 | 7678e7d514560c774b56fc0a20312d561c89f587 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.86e-05 | 75 | 112 | 4 | 7f1fc575fca42352434f7188c7a95b50372aeefa | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.40e-05 | 154 | 112 | 5 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.40e-05 | 154 | 112 | 5 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.53e-05 | 155 | 112 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.53e-05 | 155 | 112 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 4.68e-05 | 156 | 112 | 5 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | Control-Epithelial_airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.97e-05 | 158 | 112 | 5 | 35aee1c3b92169e73569331022833cb44ab7e7e8 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.12e-05 | 159 | 112 | 5 | 6c0ef40f64d2e35eaae3d0002e3c1f22d1239736 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 159 | 112 | 5 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 159 | 112 | 5 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.12e-05 | 159 | 112 | 5 | 745a59c33b04620c5329bdd50e74a8e611f2dc55 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-05 | 160 | 112 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.27e-05 | 160 | 112 | 5 | 8a41e2c96e0e170ac35daf6c403bf961b8d7c30b | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.27e-05 | 160 | 112 | 5 | d6678996e12eaf2b735f1dfae32418cb2fabf268 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.27e-05 | 160 | 112 | 5 | c8dc575562b463fd30832d322c28006f18f7ab9c | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-05 | 160 | 112 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | LPS-IL1RA-Epithelial_airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.43e-05 | 161 | 112 | 5 | 472c354f5ee148b37a5dfb795e83348ecb1643f1 | |
| ToppCell | Ciliated_cells-A-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 5.76e-05 | 163 | 112 | 5 | 43194c6127df1ce3d29242f719645de3c11fd7c0 | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.93e-05 | 164 | 112 | 5 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.93e-05 | 164 | 112 | 5 | 9e16e52f5a634585f26021bcce9b5d5992ff6db0 | |
| Disease | Colorectal Carcinoma | TET2 ABCA12 FSTL5 GRIN2A CUBN LRRC4 PREX2 ZNHIT6 AKAP9 CCAR1 KRT20 SPAG17 | 8.57e-06 | 702 | 106 | 12 | C0009402 |
| Disease | bipolar I disorder | 1.60e-04 | 141 | 106 | 5 | EFO_0009963 | |
| Disease | insomnia measurement | 2.03e-04 | 443 | 106 | 8 | EFO_0007876 | |
| Disease | lung squamous cell carcinoma (is_marker_for) | 2.95e-04 | 36 | 106 | 3 | DOID:3907 (is_marker_for) | |
| Disease | X-12063 measurement | 5.71e-04 | 186 | 106 | 5 | EFO_0021283 | |
| Disease | reaction time measurement | 6.21e-04 | 658 | 106 | 9 | EFO_0008393 | |
| Disease | Glioblastoma Multiforme | 7.01e-04 | 111 | 106 | 4 | C1621958 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 8.24e-04 | 12 | 106 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | nicotine dependence (implicated_via_orthology) | 8.24e-04 | 12 | 106 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | Congenital myopathy (disorder) | 8.24e-04 | 12 | 106 | 2 | C0270960 | |
| Disease | response to beta blocker, heart rate | 1.15e-03 | 57 | 106 | 3 | EFO_0004326, EFO_0007766 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 1.33e-03 | 60 | 106 | 3 | C4722327 | |
| Disease | Prostate cancer, familial | 1.99e-03 | 69 | 106 | 3 | C2931456 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 1.99e-03 | 69 | 106 | 3 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | superior temporal gyrus volume measurement | 2.10e-03 | 19 | 106 | 2 | EFO_0010331 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 2.41e-03 | 801 | 106 | 9 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | Headache, HbA1c measurement | 2.57e-03 | 21 | 106 | 2 | EFO_0004541, HP_0002315 | |
| Disease | Glioblastoma | 2.92e-03 | 79 | 106 | 3 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 3.48e-03 | 84 | 106 | 3 | C0334588 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QTQQQTQEMKEMYQN | 701 | Q5TYW2 | |
| YVEVVNMDAAVQQQM | 326 | P24298 | |
| NIMNMNKQSKLYSQG | 91 | Q8NDL9 | |
| ELDEMYGQQIVQMKQ | 436 | Q99996 | |
| KERYENMMQQQKLTN | 1621 | Q8NDM7 | |
| QERYMTEMQQKNKSV | 421 | Q8TC20 | |
| KTQQQTQEMKEMYQN | 701 | Q5CZ79 | |
| NAMLKVFENQANMLE | 276 | Q96M83 | |
| MQMQLYLQQLQKVQP | 926 | O60885 | |
| ENMNLQFENQMNKTI | 1101 | Q8IX12 | |
| LNMDQFLEQALQMNY | 511 | Q86UK0 | |
| QTQQQTQEMKEMYQN | 701 | Q4UJ75 | |
| EIQEMAQNKFIMLNL | 86 | Q8TD06 | |
| IEMQYMQRKQQTSAF | 231 | Q6ZU67 | |
| NENVINGQDYEVMMQ | 601 | P18850 | |
| QAAKIMERMVNQNTY | 281 | Q9UI46 | |
| LSQTQCQMKEMEQKY | 1101 | Q9UPS8 | |
| SNNSMENYLSKMQQE | 1641 | Q9UPS8 | |
| LLQELKMYQRQCQAM | 251 | Q05D60 | |
| NQRMIVCNQVMKYIL | 2691 | Q12830 | |
| QFIMNQIYEDMRQQE | 191 | Q8TC90 | |
| QVSLEKNMQLLQQMY | 986 | Q6ZS30 | |
| TSMMQEPNYQQELSK | 396 | Q9H4I0 | |
| SSANMQYQGQQMKAL | 896 | Q96EV2 | |
| MDSYNKQRMPQEITN | 271 | Q96RI1 | |
| QTQQQTQEMKEMYQN | 701 | Q5SQ80 | |
| KYSEMNNQIDIMQLQ | 101 | O43827 | |
| QEAQMNLMKQAVEIY | 201 | Q96NW4 | |
| LQMQYQQSMQLEERA | 41 | Q9Y6D9 | |
| AQLQEMKNQSMNLFQ | 151 | Q92805 | |
| YLAAMNQKREVMQQI | 1331 | Q9UKN7 | |
| QKMYQMFNETTSQVR | 821 | Q13201 | |
| FAINLKQLNVQMNMS | 4406 | Q2LD37 | |
| CQQQMPEYNITENMI | 941 | P98073 | |
| NLQDKNLMAQLQETM | 1171 | Q14C86 | |
| MAEIRDQMQQQLNDY | 346 | P20700 | |
| MMQEQITDKNSLAYQ | 141 | Q9HCG8 | |
| SQTFYEKLQEMQIQM | 1686 | Q5H9U9 | |
| MDVGKQAMQYQVLNE | 271 | O95544 | |
| SMLQDMNFINNYKID | 621 | O00408 | |
| EMLQMEQQFQQKTAV | 606 | Q6ZU52 | |
| NTRYLNLMENNIQMI | 76 | Q9HBW1 | |
| VSYQETQQMQMKFQQ | 396 | Q86UP2 | |
| MMQAISNNKDQATYE | 116 | P05976 | |
| QVKLLEEKNTMYMQN | 336 | Q86VS8 | |
| EQTYRKNVQQMMQCL | 146 | Q0VAM2 | |
| EMRQKYEVMAQKNLQ | 241 | P35900 | |
| MLLDLQNQKYIMQEN | 151 | Q8N475 | |
| PDNVLKNMVVQTNMY | 131 | Q8N414 | |
| VYRQANNINMLKEGM | 466 | Q9BWT3 | |
| YMMKQPQGEQIQINF | 736 | O60494 | |
| QTQQQTQEMKEMYQN | 701 | Q5VUR7 | |
| VQQLEDMYNKMAKTQ | 526 | Q14721 | |
| EQKMMTQTFQEQNLL | 381 | Q8NCX0 | |
| NEKILMMINQYQSDE | 1506 | Q92608 | |
| QQMQKLLEETQLDMN | 141 | Q8IWX8 | |
| QMLQDEMFKLVQLQQ | 2046 | Q9H799 | |
| EMFKLVQLQQINFMS | 2051 | Q9H799 | |
| DNQVQLQNLMMSKYL | 1451 | Q9UFH2 | |
| IYFIAQAMNNAMKEN | 356 | P51841 | |
| VQILMKIEYMQQNLV | 401 | Q9NWK9 | |
| ENLVQELSQSNMMLY | 406 | Q68CZ6 | |
| MNQNLDIYEQQVMTA | 86 | P43251 | |
| ACYNQVKIQMDQFMQ | 611 | Q13753 | |
| ALQKQQKQNYEEMQA | 311 | P0CAP2 | |
| KGTQEMKNNYNIMEI | 86 | P21781 | |
| LPMINNVMYFQINNK | 171 | Q12864 | |
| YNSQMKRAIEQESQM | 631 | P54277 | |
| QQLLNVQEEMSEMQK | 1141 | Q02224 | |
| KDIMIQFKQYMQNQN | 656 | Q13620 | |
| YLQNNEIEKMNLTVM | 306 | Q99983 | |
| MGQDTDMLNTYQQLV | 1 | Q3SY00 | |
| NNIDNMYRNFQMEVL | 241 | Q32P41 | |
| FLEKQNEQAKEMQQM | 1146 | Q15147 | |
| EMQMINQYCKDTRQQ | 701 | Q99985 | |
| QQAQYILMEFMKTRQ | 891 | A2VDJ0 | |
| MQTQMDKLQLKVQNY | 1876 | Q9Y2K3 | |
| MKLAQQYVMTSLQQE | 1001 | Q05397 | |
| VQTLLQQMQDKFQTM | 16 | O75506 | |
| QQMQDKFQTMSDQII | 21 | O75506 | |
| MNPAEVVKQRLQMYN | 161 | Q9NYZ2 | |
| FLNNNNQMVLDMILY | 11 | Q6NSI8 | |
| MFMNIEKTLVQNNCL | 151 | Q92922 | |
| YSQQLRMIMGIIQQK | 966 | O94855 | |
| IRQQYVMKMNTQEAK | 646 | Q6Q759 | |
| YQKQMEVLETRMNVN | 101 | Q8NEL0 | |
| TLMSYNILAQDLMQQ | 246 | Q9UNK9 | |
| ANKMQQLNNMDEVCY | 691 | Q8N3C0 | |
| MNTQILLMAVKNNSY | 41 | Q5U649 | |
| QKKQLKEQQEMQQMY | 441 | Q8IWZ8 | |
| ILIAQRNEMQQKLYM | 436 | Q9BXU1 | |
| KINQEEQRPVQMMYQ | 186 | P50453 | |
| NTERKQNQNYFMEVM | 771 | Q9Y5W7 | |
| QKFRYNELMQALNMS | 1841 | Q15413 | |
| IQKQQESYMAQVLDQ | 171 | Q86W54 | |
| MIKYQKELNEMQAQI | 1081 | O75116 | |
| MNMLYSQLVEALSNN | 911 | Q8IYF3 | |
| QLMAALNQMFDNSKE | 1281 | Q70Z35 | |
| QRNNMLQTMDYEKSV | 536 | Q6AHZ1 | |
| QNFEEQMQGMKTQLI | 486 | Q8TC07 | |
| MMQQNYSEALEVVNQ | 191 | Q8NDW8 | |
| QMNLYKEVMLENFSN | 56 | Q3KNS6 | |
| NEYNKSELMLQENQM | 351 | Q8N9V7 | |
| MDQQFEEMNNKLNSV | 1326 | Q96AY4 | |
| QQMAPVQKNLYRDVM | 61 | Q9Y2H8 | |
| NEKKQQMIMENQNSE | 186 | Q9BXG8 | |
| TDLMNMIQKENACNQ | 521 | Q8TE54 | |
| QLEHKSQMYQVEMNQ | 626 | Q6N021 | |
| KVGKLVNQSYMMSQN | 71 | A8MT70 | |
| VNQSYMMSQNKGNVV | 76 | A8MT70 | |
| NMLIAMINNSYQEIE | 666 | Q9HCX4 | |
| QLMDLTQDNVKNQYV | 1221 | Q5THJ4 | |
| LQKAMMQILQEKNRY | 661 | P20592 | |
| QKQLQQQNEKEMMEQ | 1501 | B2RTY4 | |
| LKENMVYQFQVAAMN | 1001 | P52179 | |
| IQQQATVMLKIMQDY | 151 | Q12879 | |
| KNMMQIQSDNVYKED | 1181 | P20929 | |
| LAKNMMQIQSDNQYK | 1911 | P20929 |